129 related articles for article (PubMed ID: 2675077)
1. The pathophysiological role of PAF in anaphylactic lung reaction in the guinea pig and in endotoxin shock evidenced by the specific PAF-antagonist WEB 2086.
Heuer H; Casals-Stenzel J
Prog Clin Biol Res; 1989; 308():925-30. PubMed ID: 2675077
[No Abstract] [Full Text] [Related]
2. Effects of WEB 2086, a novel antagonist of platelet activating factor, in active and passive anaphylaxis.
Casals-Stenzel J
Immunopharmacology; 1987 Apr; 13(2):117-24. PubMed ID: 3597059
[TBL] [Abstract][Full Text] [Related]
3. Effect of the hetrazepinoic platelet-activating factor antagonist Bepafant (WEB 2170) in models of active and passive anaphylaxis in mice and guinea pigs.
Heuer HO
Lipids; 1991 Dec; 26(12):1374-80. PubMed ID: 1819736
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of WEB 2086, a novel antagonist of platelet activating factor, in endotoxin shock.
Casals-Stenzel J
Eur J Pharmacol; 1987 Mar; 135(2):117-22. PubMed ID: 3582490
[TBL] [Abstract][Full Text] [Related]
5. Characterization of cardiovascular events mediated by platelet activating factor during systemic anaphylaxis.
Felix SB; Baumann G; Hashemi T; Niemczyk M; Ahmad Z; Berdel WE
J Cardiovasc Pharmacol; 1990 Jun; 15(6):987-97. PubMed ID: 1694923
[TBL] [Abstract][Full Text] [Related]
6. Effect of the PAF-antagonist WEB 2086 on anaphylactic lung reaction: comparison of inhalative and intravenous challenge.
Heuer H; Casals-Stenzel J
Agents Actions Suppl; 1988; 23():207-15. PubMed ID: 3262991
[TBL] [Abstract][Full Text] [Related]
7. Effect of PAF-antagonists in endotoxin shock--ovine and rat experiments.
Bahrami S; Redl H; Thurnher M; Vogl C; Paul E; Schiesser A; Schlag G
Prog Clin Biol Res; 1989; 308():931-6. PubMed ID: 2780740
[No Abstract] [Full Text] [Related]
8. Protective effect of SR 27417, a novel PAF antagonist, on lethal anaphylactic and endotoxin-induced shock in mice.
Herbert JM; Lespy L; Maffrand JP
Eur J Pharmacol; 1991 Dec; 205(3):271-6. PubMed ID: 1817964
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor (TNF) and endotoxin prime effects of PAF in vivo.
Heuer HO; Letts G; Meade CJ
J Lipid Mediat; 1990; 2 Suppl():S101-8. PubMed ID: 2133276
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of active anaphylaxis in mice and guinea pigs by the new hetrazepinoic PAF antagonist bepafant (WEB 2170).
Heuer HO
Eur J Pharmacol; 1991 Jun; 199(2):157-63. PubMed ID: 1954975
[TBL] [Abstract][Full Text] [Related]
11. WEB 2347: pharmacology of a new very potent and long acting hetrazepinoic PAF-antagonist and its action in repeatedly sensitized guinea-pigs.
Heuer HO
J Lipid Mediat; 1991; 4(1):39-44. PubMed ID: 1893086
[TBL] [Abstract][Full Text] [Related]
12. Interference of the PAF-acether antagonist BN 52021 with anaphylaxis in the guinea pig.
Desquand S; Vilain B; Lagente V; Randon J; Touvay C; Lefort J; Braquet P; Vargaftig BB
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():818-21. PubMed ID: 2445183
[No Abstract] [Full Text] [Related]
13. Effect of a new and specific PAF-antagonist, WEB 2086, on PAF and endotoxin/tumor necrosis factor induced changes in mortality and intestinal transit velocity.
Heuer H
Prog Clin Biol Res; 1989; 308():919-24. PubMed ID: 2780739
[No Abstract] [Full Text] [Related]
14. Interference by the novel PAF-acether antagonist WEB 2086 with the bronchopulmonary responses to PAF-acether and to active and passive anaphylactic shock in guinea-pigs.
Pretolani M; Lefort J; Malanchère E; Vargaftig BB
Eur J Pharmacol; 1987 Aug; 140(3):311-21. PubMed ID: 3653247
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor.
Casals-Stenzel J; Muacevic G; Weber KH
J Pharmacol Exp Ther; 1987 Jun; 241(3):974-81. PubMed ID: 3598913
[TBL] [Abstract][Full Text] [Related]
16. Idiopathic thrombocytopenia treated with Paf-acether antagonist WEB 2086.
Lohmann HF; Adamus WS; Meade CJ
Lancet; 1988 Nov; 2(8620):1147. PubMed ID: 2903365
[No Abstract] [Full Text] [Related]
17. Inhibitory effects of a novel PAF antagonist E6123 on anaphylactic responses in passively and actively sensitized guinea pigs and passively sensitized mice.
Sakuma Y; Muramoto K; Harada K; Katayama S; Tsunoda H; Katayama K
Prostaglandins; 1991 Dec; 42(6):541-55. PubMed ID: 1801063
[TBL] [Abstract][Full Text] [Related]
18. Involvement of platelet-activating factor (PAF) in septic shock and priming as indicated by the effect of hetrazepinoic PAF antagonists.
Heuer HO
Lipids; 1991 Dec; 26(12):1369-73. PubMed ID: 1819735
[TBL] [Abstract][Full Text] [Related]
19. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF).
Merlos M; Giral M; Balsa D; Ferrando R; Queralt M; Puigdemont A; García-Rafanell J; Forn J
J Pharmacol Exp Ther; 1997 Jan; 280(1):114-21. PubMed ID: 8996188
[TBL] [Abstract][Full Text] [Related]
20. The booster injection of antigen during active sensitization of guinea-pig modifies the anti-anaphylactic activity of the PAF antagonist WEB 2086.
Desquand S; Lefort J; Dumarey C; Vargaftig BB
Br J Pharmacol; 1990 Jun; 100(2):217-22. PubMed ID: 2379029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
